Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
156
datasets available to search
ShareScore release 0.9.0
Dataset results
156 results for “vascular access”
REtrospective Analysis on the Use of COvered Stents for the Treatment of the Dysfunctional Vascular Access
ClinicalTrials.gov study NCT04897828. IPD Sharing: NO. Countries: 0. Publications: 0.
HeRO Vascular Access Device Post Market Procedural Survey Protocol
ClinicalTrials.gov study NCT00889291. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Cystic Fibrosis and Totally Implantable Vascular Access Devices
ClinicalTrials.gov study NCT00244270. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Prospective Registry on Vascular Access in Interventions in Lazio Region
ClinicalTrials.gov study NCT00674778. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dataset related to article "Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications"
<p>This record contains raw data related to article “Long term follow-up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications"</p> <p>Abstract</p> <p><strong>Objectives: </strong> To report the experience of a high-volume center with balloon-expandable (BE) stents implantation to manage vascular complications after transcatheter aortic valve replacement (TAVR).</p> <p><strong>Background: </strong> Despite increased operator experience and better devices, vascular complications after TAVR are still a major issue and covered stent implantation is often required.</p> <p><strong>Methods: </strong> We retrospectively collected baseline and procedural data about 78 consecutive patients who underwent BE stent implantation to manage a vascular complication after transfemoral TAVR. Primary endpoints were technical success, incidence of new-onset claudication and need for vascular interventions during long-term follow-up. Secondary endpoints included length of hospitalization, in-hospital and 30-day mortality, and major postoperative complications.</p> <p><strong>Results: </strong> BE stents implantation to manage vascular complications after TAVR was successfully performed in 96.2% of the cases, with bailout surgery required in two cases. One patient suffered in-hospital death. Predischarge Doppler Ultrasound revealed no cases of in-stent occlusion or fracture. At a median follow-up of 429 days (interquartile range, 89-994 days), no cases of symptomatic leg ischemia were reported and only one patient experienced new-onset claudication.</p> <p><strong>Conclusions: </strong> Our experience showed good periprocedural and long-term results of BE covered stent implantation to manage vascular complication after TAVR. Their great radial outward force may guarantee effective hemostasis without necessarily being associated with stent deformation/fracture resulting in restenosis or further interventions. More research is needed to define the role of BE covered stents in this setting.</p>
Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular Disease and Dialysis Access
ClinicalTrials.gov study NCT07141641. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Individual Patient Expanded Access for Acellular Tissue Engineered Vessel (ATEV) for Vascular System Injuries
ClinicalTrials.gov study NCT03631056. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies
ClinicalTrials.gov study NCT03317366. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Mesenchymal Stem Cell Transplantation Attenuates Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula
GEO Series GSE179959. Homo sapiens; Mus musculus; Sus scrofa. 27 samples. Type: Expression profiling by high throughput sequencing.
Mesenchymal Stem Cell Transplantation Attenuates Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula [P33 GV RAW]
GEO Series GSE179956. Sus scrofa. 9 samples. Type: Expression profiling by high throughput sequencing.
Mesenchymal Stem Cell Transplantation Attenuates Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula [P33_MSC]
GEO Series GSE179957. Sus scrofa. 3 samples. Type: Expression profiling by high throughput sequencing.
Mesenchymal Stem Cell Transplantation Attenuates Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula [Mouse MSC]
GEO Series GSE179955. Mus musculus. 3 samples. Type: Expression profiling by high throughput sequencing.
Mesenchymal Stem Cell Transplantation Attenuates Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula [Mouse GV_MSCvsNT]
GEO Series GSE179953. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.
Mesenchymal Stem Cell Transplantation Attenuates Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula.
GEO Series GSE223511. Mus musculus. 11 samples. Type: Expression profiling by high throughput sequencing.
Vascular access and clinical competency: Which elements matter? The development of three bottom-up and evidence-grounded self-assessment tools
<p>Dataset from Rigo C, Grazioli M, Caravella G, Ursino F, Zerla P, Magon A, Dellafiore F, Caruso R. Vascular access and clinical competency: Which elements matter? The development of three bottom-up and evidence-grounded self-assessment tools. J Vasc Access. 2021 Jun 18:11297298211026447. doi: 10.1177/11297298211026447. Epub ahead of print. PMID: 34148385.</p> <p>Abstract</p> <p><strong>Background: </strong>Assessing competency in the speciality of vascular access is still limited, and few valid and reliable tools are available. Therefore, this study aimed to develop and validate three different tools for assessing competency in managing the care of short peripheral cannulas (SPCs), midlines, peripherally inserted central catheters (PICCs), centrally inserted central catheters (CICCs), and arterial catheters (ACs) (tool one), placing SPCs (tool two), placing PICCs and midlines (tool three).</p> <p><strong>Methods: </strong>A two-phase and multi-method design was adopted. Phase one was implemented to develop the initial pool of items for each tool, starting from a literature overview. Panel discussions were adopted for developing the items. In phase two, the developed items were tested for content and face validity, involving a panel of 10 experts. Once obtained adequate content validity, a cross-sectional data collection was implemented to enroll three samples of healthcare workers who had to assess their competency through the developed tools. Dimensionality was assessed by performing a principal component analysis (PCA) and assessing internal consistency (Cronbach's α).</p> <p><strong>Results: </strong>Tool one had 26 items, and the dimensionality was given by placement, risk assessment, procedure conformity and traceability, and patient education to self-care. Tool two had 35 items; its principal components were: risk evaluation, identification, clinical assessment and orientation to self-care, placement, and procedure registration shaped the competency of placing SPCs. Tool three had 31 items; its principal components were: risk assessment, placement, conformity to standards and procedure traceability, education, and orientation to self-care were the essential elements for adequately placing midlines and PICCs. Cronbach's α values ranged between 0.806 and 0.959.</p> <p><strong>Conclusions: </strong>The three developed tools reflected the core elements of competency in each application area, representing an initial framework that could be useful in future research and educational projects. Cross-national investigations are required to corroborate the described results.</p>
Mesenchymal Stem Cell Transplantation Attenuates Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula [Human MSC]
GEO Series GSE179954. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.